Enoximone

Enoximone

SCHEMBL44049

CSc1ccc(C(=O)c2[nH]c(=O)[nH]c2C)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PDE3APDE3B

The experimentally established mechanism targets of Enoximone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B known ✓ Q13370 3/20 1.00
PDE3A known ✓ Q14432 3/20 1.00
PDE4A P27815 11/20 1.00
PDE4B Q07343 11/20 1.00
PDE4C Q08493 11/20 1.00
PDE4D Q08499 11/20 1.00
TSHR P16473 2/20 1.00
CYP1A2 P05177 1/20 1.00
CYP3A4 P08684 1/20 1.00
CYP2C9 P11712 1/20 1.00
HPGD P15428 1/20 1.00
ALOX15 P16050 1/20 1.00
NFKB1 P19838 1/20 1.00
BLM P54132 1/20 1.00
PMP22 Q01453 1/20 1.00
ATM Q13315 1/20 1.00
NPSR1 Q6W5P4 1/20 1.00
HSD17B10 Q99714 1/20 1.00
PLK1 P53350 1/20 0.42
MMP2 P08253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Enoximone SCHEMBL5153559 1.00 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DPDE3B
Enoximone SCHEMBL5702415 0.94 PDE4A (0.89) PDE4APDE4BPDE4CPDE4DPDE3B
Enoximone SCHEMBL28068937 0.85 PDE4A (0.72) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7442148 0.83 PDE4A (0.70) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9787151 0.83 PDE4A (0.70) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL5457930 0.81 PDE4A (0.69) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10635511 0.81 PDE4A (0.69) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL7416132 0.80 PDE4A (0.67) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL11181578 0.80 PDE4A (0.67) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10924200 0.80 PDE4A (0.67) PDE4APDE4BPDE4CPDE4DPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5648 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724049-A1 MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF Catalent Ontario Limited (CA) 2026-04-15 EP claimed
EP-4081242-B1 TREATMENT OF ACUTE HEART FAILURE AnaCardio R&D AB (SE) 2025-09-10 EP claimed
EP-4561649-A1 DRUG-COATED MEDICAL DEVICES AND METHODS OF MAKING Bard Peripheral Vascular, Inc. (US) 2025-06-04 EP claimed
CN-120018870-A Drug coated medical device and method of manufacture 巴德血管外围设备公司 2025-05-16 CN claimed
CN-119746100-A Engineering long-acting platelet delivery system with therapeutic drug carried therein, and preparation method and application thereof 沈阳药科大学 2025-04-04 CN claimed
WO-2025038398-A1 METHODS OF PREVENTING OR TREATING LIVER DISEASE UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2025-02-20 WO claimed
WO-2025023975-A1 METHODS FOR THE PREPARATION OF PHOSPHOLIPID BILAYER CARRIERS BARD PERIPHERAL VASCULAR, INC. (US) 2025-01-30 WO claimed
CN-119303086-A Pharmaceutical composition for treating autism 斯塔利克拉股份有限公司 2025-01-14 CN claimed
WO-2024254056-A1 MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF CATALENT ONTARIO LIMITED (CA) 2024-12-12 WO claimed
WO-2024242668-A1 PROTECTIVE COVERINGS FOR DRUG COATED BALLOONS BARD PERIPHERAL VASCULAR, INC. (US) 2024-11-28 WO claimed
WO-1998058638-A1 METHOD OF TREATING HEART FAILURE BRISTOW MICHAEL R (US) 1998-12-30 WO claimed
WO-1998010765-A1 NON-HORMONAL METHOD OF CONTRACEPTION THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 1998-03-19 WO claimed
EP-0326103-B1 PHARMACEUTICAL COMPOSITION FOR 4-AROYLIMIDAZOL-2-ONES MERRELL DOW PHARMACEUTICALS INC. (US) 1992-07-15 EP claimed
EP-0169164-B1 IMIDAZOLONECARBONYLARYLIMIDAZOLES; METHOD OF MANUFACTURE, METHOD OF USE AND COMPOSITIONS USEFUL THEREOF SCHERING AKTIENGESELLSCHAFT (DE) 1990-01-31 EP claimed
US-4868182-A HYPOTENSIVE AND CARDIOTONIC, SYNERGISTIC MERRELL DOW PHARMACEUTICALS INC. (US) 1989-09-19 US claimed
EP-0326103-A1 Pharmaceutical composition for 4-aroylimidazol-2-ones MERRELL DOW PHARMACEUTICALS INC. (US) 1989-08-02 EP claimed
EP-0268146-A1 Enhancement of prazosin MERRELL DOW PHARMACEUTICALS INC. (US) 1988-05-25 EP claimed
US-4709043-A Process for the preparation of imidazolonecarbonylarylimidazoles SCHERING A.G. (DE) 1987-11-24 US claimed
EP-0169164-A1 Imidazolonecarbonylarylimidazoles; method of manufacture, method of use and compositions useful thereof SCHERING AKTIENGESELLSCHAFT (DE) 1986-01-22 EP claimed
US-4405635-A HYPOTENSIVE, CARDIOTONIC, BRONCHODILATOR, ANTICOAGULANT, AND MUSCLE RELAXANT AGENTS MERRELL DOW PHARMACEUTICALS INC. (US) 1983-09-20 US claimed